Fresh Tracks Therapeutics Inc logo

Fresh Tracks Therapeutics Inc

$ 1.94 +0.13 (+7.18%) 10:08 PM EST
P/E:
At Loss
P/B:
0.52
Market Cap:
$ 5.85M
Enterprise V:
$ -5.39M
Volume:
5.03K
Avg Vol (2M):
46.09K
Also Trade In:
Volume:
5.03K
Market Cap $:
5.85M
PE Ratio:
At Loss
Avg Vol (2-Month):
46.09K
Enterprise Value $:
-5.39M
PB Ratio:
0.52
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics.
Name Current Vs Industry Vs History
Cash-To-Debt 625
Equity-to-Asset 0.78
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -18.51
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 50.39
9-Day RSI 50.85
14-Day RSI 50.38
6-1 Month Momentum % -69.21
12-1 Month Momentum % -85.89

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.43
Quick Ratio 4.43
Cash Ratio 3.49
Days Sales Outstanding 20.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -237.1

Financials (Next Earnings Date:2023-03-09 Est.)

FRTX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FRTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4.997
EPS (TTM) ($) -8.8
Beta 0.39
Volatility % 66.57
14-Day RSI 50.38
14-Day ATR ($) 0.176974
20-Day SMA ($) 1.9
12-1 Month Momentum % -85.89
52-Week Range ($) 1.67 - 18.945
Shares Outstanding (Mil) 3.01

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Fresh Tracks Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Fresh Tracks Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.